Core Viewpoint - The company Inke Medical has seen a significant increase in its stock price, closing at 29.77 yuan with a rise of 5.12%, while its rolling PE ratio has reached a new low of 12.09 times over the past 190 days, indicating potential undervaluation compared to the industry average [1] Company Summary - Inke Medical specializes in the research, production, and sales of high-performance personal protective products, including disposable nitrile gloves, PVC gloves, PE gloves, isolation gowns, masks, electric wheelchairs, manual wheelchairs, mobility scooters, walkers, electric sofas, bedside tables, ice/hot packs, hand sanitizers, heating pads, cooling mats, ECG electrodes, and label electrodes [1] - For the first quarter of 2025, the company reported a revenue of 2.494 billion yuan, representing a year-on-year increase of 13.20%, and a net profit of 353 million yuan, reflecting a year-on-year growth of 48.08%, with a gross profit margin of 24.16% [1] Industry Summary - The average PE ratio for the medical device industry stands at 51.87 times, with a median of 37.48 times, positioning Inke Medical at the 32nd rank within the industry [1] - As of the first quarter of 2025, a total of 18 institutions hold shares in Inke Medical, including 16 funds, 1 social security fund, and 1 other entity, with a total holding of 52.99 million shares valued at 1.266 billion yuan [1]
英科医疗收盘上涨5.12%,滚动市盈率12.09倍,总市值191.07亿元